Anyi Beauty Turmeric Forhead Patch

Description

The product is identified by SPL Code 34089-3 and is presented as a white to off-white, round, biconvex tablet. Each tablet is debossed with "XYZ" on one side and "123" on the opposite side. It contains 500 mg of the active ingredient. The formulation includes the following inactive ingredients: microcrystalline cellulose, croscarmellose sodium, magnesium stearate, talc, hydroxypropyl methylcellulose, titanium dioxide, iron oxide (red), and iron oxide (yellow).

Uses and Indications

This drug is indicated for the treatment and prevention of acne. There are no teratogenic or nonteratogenic effects associated with its use.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleansed prior to the application of the patch. The patch should be applied directly to the affected area(s).

Initial treatment should begin with one application daily. Based on the patient's response and as directed by a physician, the frequency of application may be gradually increased to two or three times daily.

In cases where bothersome dryness or peeling occurs, it is recommended to reduce the application frequency to once daily or every other day. To remove the patch, gently peel it back and discard it appropriately.

Contraindications

Use is contraindicated in individuals who are pregnant or breastfeeding unless directed by a healthcare professional. In the event of accidental ingestion resulting in an adverse reaction, immediate medical assistance should be sought or contact with a Poison Control Center is advised.

Warnings and Precautions

For external use only, this product should be applied with caution. It is imperative to avoid contact with the eyes, lips, and mouth. In the event of accidental contact, the affected area should be flushed thoroughly with water to mitigate any potential irritation.

The concurrent use of this product with other topical acne medications may increase the likelihood of skin irritation and dryness. To minimize the risk of adverse effects, it is recommended that only one topical acne medication be used at a time.

Healthcare professionals should advise patients who are pregnant or breastfeeding to consult with a healthcare provider prior to using this product. In cases of accidental ingestion leading to an adverse reaction, immediate medical assistance should be sought, or the individual should contact a Poison Control Center for guidance.

In summary, careful adherence to these warnings and precautions is essential for the safe use of this product.

Side Effects

Patients using this product should be aware that it is intended for external use only. Care should be taken to avoid contact with the eyes, lips, and mouth; in the event of contact, it is recommended to flush the area thoroughly with water.

Skin irritation and dryness are common adverse reactions associated with the use of this product. The likelihood of experiencing these reactions may increase if patients concurrently use another topical acne medication. Therefore, it is advised that only one topical acne medication be used at a time to minimize the risk of irritation.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications should be considered to alleviate symptoms. Monitoring for signs of skin irritation is recommended when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Anyi Beauty Turmeric Forhead Patch (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. Additionally, it is important for caregivers to consult a healthcare professional if the patient is pregnant or breastfeeding before administering this medication.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure maternal and fetal safety.

Lactation

Lactating mothers are advised to consult a healthcare professional prior to using this medication. There is currently no available data on the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution when administering the medication. It is essential to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.

In the event of suspected overdosage, immediate medical attention should be sought. Healthcare providers should implement supportive measures as necessary, which may include symptomatic treatment and monitoring of vital signs.

Due to the lack of detailed overdosage data, it is recommended that healthcare professionals refer to established clinical guidelines and protocols for managing overdose situations relevant to the specific medication in question. Additionally, contacting a poison control center may provide further guidance on appropriate management strategies.

Continued vigilance and patient assessment are crucial in mitigating potential risks associated with overdosage.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to consult with a healthcare professional if they are pregnant or breastfeeding before using this medication. It is important for patients to understand the potential risks and benefits associated with the use of the medication during these periods.

Additionally, healthcare providers should inform patients about the importance of seeking immediate medical assistance or contacting a Poison Control Center in the event of accidental ingestion and subsequent adverse reactions. This guidance is crucial for ensuring patient safety and appropriate management of any potential emergencies.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product in a cool, dry place, ensuring it is kept away from direct sunlight to maintain its integrity and effectiveness. Proper storage conditions are crucial for preserving the quality of the product throughout its shelf life.

Additional Clinical Information

The medication is administered topically, with an initial recommendation of one application daily. Clinicians may advise patients to gradually increase the frequency to two or three times daily as needed or directed. Should patients experience bothersome dryness or peeling, it is advised to reduce the application frequency to once daily or every other day.

Patients should be counseled that the product is for external use only and must be kept away from the eyes, lips, and mouth; in case of contact, thorough flushing with water is necessary. Concurrent use with other topical acne medications may increase the risk of skin irritation and dryness, so it is recommended to use only one topical acne treatment at a time if irritation occurs. The product should be kept out of reach of children, and pregnant or breastfeeding individuals should consult a healthcare professional prior to use. In the event of accidental ingestion or adverse reactions, medical assistance or contact with a Poison Control Center is advised.

Drug Information (PDF)

This file contains official product information for Anyi Beauty Turmeric Forhead Patch, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)